BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:29 PM
 | 
Oct 24, 2012
 |  BC Extra  |  Financial News

Regeneron gains on 3Q12 results, Eylea guidance

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) gained $9.70 to $162.69 on Wednesday after reporting the third full quarter of sales for Eylea aflibercept and raising guidance for the ophthalmic drug for the fourth time this year. Eylea,...

Read the full 162 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >